Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
Abstract 3,4-Methylenedioxymethamphetamine (MDMA) is currently being evaluated by the Food and Drug Administration (FDA) for the treatment of post-traumatic stress disorder (PTSD). If MDMA is FDA-approved it will be important to understand what medications may pose a risk of drug–drug interactions....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/b5fcb5c6d48f493398295aa1b6997412 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|